Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 88.58B P/E 13.73 EPS this Y 13.60% Ern Qtrly Grth -
Income 3.62B Forward P/E 10.61 EPS next Y 12.30% 50D Avg Chg 9.00%
Sales 204.15B PEG 0.99 EPS past 5Y 10.08% 200D Avg Chg 4.00%
Dividend 2.00% Price/Book 1.99 EPS next 5Y 11.97% 52W High Chg -12.00%
Recommedations 1.80 Quick Ratio 0.58 Shares Outstanding 284.07M 52W Low Chg 24.00%
Insider Own 1.55% ROA 3.08% Shares Float 282.72M Beta 0.53
Inst Own 90.41% ROE 8.97% Shares Shorted/Prior 3.78M/3.28M Price 299.40
Gross Margin 11.61% Profit Margin 1.77% Avg. Volume 1,663,237 Target Price 393.25
Oper. Margin 0.81% Earnings Date Aug 1 Volume 1,967,405 Change 1.27%
About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.

CI Chatroom

User Image MarketDragon Posted - 11 hours ago

Stock Performance for $CI over the Last Month: Opening Price: $343.98 Closing Price: $340.82 Highest Price: $347.37 Lowest Price: $316.55 Percentage Change: -0.92% For more information: https://www.sahg6dtr.com/3K2CLMD/R74QP/

User Image MarketDragon Posted - 1 day ago

Stock Performance for $CI over the Last Month: Opening Price: $342.16 Closing Price: $335.79 Highest Price: $347.37 Lowest Price: $316.55 Percentage Change: -1.86% For more information: https://www.sahg6dtr.com/3K2CLMD/R74QP/

User Image Aigner_Andreas Posted - 5 days ago

TD SELL $CI at 335.84, Supp 319.12 Resis 344.76 R8 HiLo 75% T1Y 314 buy 2.2 DIV 1.42% #Cigna Corp #stocks #trading #finance #market

User Image PIVOTPOINTSMUSA Posted - 6 days ago

$UNH $CI $CVS $JNJ

User Image DonCorleone77 Posted - 6 days ago

$ELV $UNH $CNC $CI $MOH Elevance Health downgraded to Neutral from Buy at BofA BofA analyst Kevin Fischbeck downgraded Elevance Health (ELV) to Neutral from Buy with a price target of $530, down from $646. In Q2, both UnitedHealth (UNH) and Elevance signaled incremental Medicaid pressure, notes the analyst, who sees this making it difficult to have conviction about where and when Medicaid margins will trough. Although some premium is warranted for Elevance, there sees the current gap to peers like Centene (CNC), Cigna (CI) and Molina Healthcare (MOH) limiting the upside, the analyst added.

User Image Katzung Posted - 1 week ago

$CI $UNH up massively from the recent sell offs. A properly timed and executed tarde would mint a fortune fomr someone with good trading discipline. I was exited the Cigna calls soon as I reached my break even price as I no longer wanted to handle the election risk. And kept a tiny position on UNH via calls which I exited soon after the 4.5% pop at market open after earnings. Made a decent gain, but no where near the max potential for that trade. Considering that even Humana is up so much from the near 300ish bottom it hit, these are clearly buy and hold names and stable for long term portfolio. Obviously not the best stocks to trade via short term options unless buying leaps.

User Image optionspayus Posted - 1 week ago

$spy $qqq it’s clear. Trump wants a lower bar for him to easily beat. He will make comments on every issue to shake up the markets. Helps him win if stock market is going down. He will bring those insurance companies down too $unh $ci

User Image optionspayus Posted - 1 week ago

$spy $qqq $unh $CI The insurance companies are sky rocketing and Obama care repeal won’t work well for Rep’s. It implies no Obama care and very high insurance costs

User Image optionspayus Posted - 1 week ago

$SPY $qqq $unh and $ci are rallying… insurance costs appear going high under Trump. A good talking point for Dem’s

User Image FolikoInvest Posted - 1 week ago

$CI A new FTC report has raised concerns about the power of pharmacy benefit managers like Cigna's Express Scripts, who have been accused of inflating drug costs and harming smaller pharmacies and consumers. With the industry facing greater regulation, will this lead to a shake-up of the pharmaceutical sector? https://folikoinsights.com/article/CI/2024/07/16/ftc-report-raises-concerns-over-cigna-and-other-pbms-influence-on-drug-prices-and-consolidation-in-t?rf=stocktwits

User Image Bionicrooster Posted - 1 week ago

$CI

User Image TampaBayBuc Posted - 1 week ago

$CI $10 drop from premarket high $341.

User Image NicholasABrown Posted - 1 week ago

$CI $MRK $TOL $MDT | Merck And 3 Other Cheap Stocks To Buy Ahead Of Earnings - Barron’s “Cigna, Merck, Toll Brothers, Medtronic could see shares gain after proving their earnings growth remains strong.” https://www.barrons.com/articles/cheap-stocks-earnings-merck-toll-medtronic-cigna-16c2e310?st=zjqhdb7izcm4ovn

User Image Americanbulls Posted - 1 week ago

$CI apparently the bear pattern is not confirmed. Prices continue to rise. www.Americanbulls.com/SignalPage.aspx?lang=en&Ticker=CI

User Image OpenOutcrier Posted - 1 week ago

$UNH $CVS $CI Federal Trade Commission to sue drug middlemen over prices of medications including insulin, source says - CNBC https://ooc.bz/l/37386

User Image Ro_Patel Posted - 2 weeks ago

Rumour: FTC plans to sue the 3 largest PBMs over their negotiating tactics for various medicines, including insulin, that pushed patients toward higher-priced treatments The FTC this week released a scathing report that found the 3 largest PBMs — $CI Express Scripts, $CVS Caremark, & $UNH OptumRx — processed nearly 80% of the roughly 6.6B prescriptions that were dispensed by US pharmacies in 2023. The report found that the prescription drug market is “highly concentrated” b/c the largest PBMs are owned by insurers and, in turn, own specialty, mail-order, or retail pharmacies, which throttles competition. The FTC said its findings were interim, though, b/c some companies did not provide all of the requested information & threatened further action.

User Image aaronwall Posted - 2 weeks ago

FTC suing the PBMs, which is why that interim report was rushed out - as pretext to begin the litigation. https://www.wsj.com/health/pharma/ftc-to-sue-drug-managers-over-insulin-prices-b46af71f $WBA up over 4% while $CVS off a percent. $CI off a half percent & $UNH up over a percent today. There is an ongoing article series in the WSJ https://www.wsj.com/finance/stocks/how-drug-middlemen-keep-beating-the-system-671a638b The “optics are not good and must be addressed,” an executive at a PBM parent organization was quoted as saying in a document obtained by the FTC. “You can get the drug…at a non-preferred pharmacy (Costco) for $97, at Walgreens (preferred) for $9000, and at preferred home delivery for $19,200…Compounding the challenge/optics is the fact that we’ve created plan designs to aggressively steer customers to home delivery where the drug cost is ~200 times higher.” ... In its report, the FTC cites experts who argue that the PBMs may have spun off these rebate aggregators as separate entities to keep more of the savings they create in their pockets instead of passing them on to employers.

User Image USSLiberty Posted - 2 weeks ago

$CI

User Image Mitz007 Posted - 2 weeks ago

$CVS $UNH $CI

User Image DonCorleone77 Posted - 2 weeks ago

$UNH $CI $CVS FTC to sue PBMs over insulin prices, WSJ reports Following a two-year investigation, the Federal Trade Commission plans to file lawsuits against the largest three pharmacy-benefit managers, or PBMs, over their tactics for negotiating prices for drugs including insulin, taking aim at the business practices related to rebates brokered with drug manufacturers, a person familiar with the matter told The Wall Street Journal's Liz Essley Whyte and Anna Wilde Mathews. The three largest PBMs - UnitedHealth Group's (UNH) OptumRx, Cigna's (CI) Express Scripts and CVS Health's (CVS) Caremark - each share a parent with a large health insurer and handle roughly 80% of U.S. prescriptions, the Journal noted

User Image Shant_Is_Back Posted - 2 weeks ago

$CLOV Haha $CVS, $UNH, and $CI Unbowed by Critical FTC Report on Pharmacy Benefit Managers https://www.marketwatch.com/articles/cvs-unh-cigna-ftc-pharmacy-benefit-managers-ee95eeba?mod=mw_latestnews

User Image DonCorleone77 Posted - 2 weeks ago

$CVS $UNH $HUM $CI FTC releases interim staff report on pharmacy benefit managers The Federal Trade Commission announced it has published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers, or PBMs, have on the accessibility and affordability of prescription drugs. "The interim staff report, which is part of an ongoing inquiry launched in 2022 by the FTC, details how increasing vertical integration and concentration has enabled the six largest PBMs to manage nearly 95 percent of all prescriptions filled in the United States. This vertically integrated and concentrated market structure has allowed PBMs to profit at the expense of patients and independent pharmacists," the FTC stated. The Commission's interim report stems from special orders the FTC issued in 2022, under Section 6(b) of the FTC Act, to the six largest PBMs-Caremark Rx, LLC; Express Scripts, Inc.; OptumRx, Inc.; Humana Pharmacy Solutions, Inc.; Prime Therapeutics LLC; and MedImpact Healthcare Systems, Inc. In 2023, the FTC issued additional orders to Zinc Health Services, LLC, Ascent Health Services, LLC, and Emisar Pharma Services LLC, which are each rebate aggregating entities, also known as "group purchasing organizations," that negotiate drug rebates on behalf of PBMs, the FTC noted.

User Image Katzung Posted - 2 weeks ago

$CI https://www.statnews.com/pharmalot/2024/07/09/pbm-pharmacies-cvs-optum-humana-cigna-pharmaceuticals-medicines-prescriptions-antitrust/ Is this the reason for the pre-market weakness?

User Image Katzung Posted - 2 weeks ago

$CI Trying to bounce off and stay above the 200dma.. hopefully closes above that.

User Image maddy007a Posted - 2 weeks ago

$CI why is this not going up!!! Last week was horrible and this week this is crawling verrrrryyyyy slow!!

User Image maddy007a Posted - 2 weeks ago

$CI all of heathcare is recovering except $CI Hopefully this gets back on now!!!

User Image anil218 Posted - 2 weeks ago

$CI Easy 340+…

User Image Stocksrunner Posted - 2 weeks ago

$CI Cigna's stock options are seeing high implied volatility, suggesting potential market moves. Investors should watch for any news related to their healthcare services and market positioning.

User Image profit_guru Posted - 2 weeks ago

$CI - stock bottomed..expect algo dip buying into close…near term 340…imo

User Image maddy007a Posted - 2 weeks ago

$CI not sure why $CI is taking a bigger hit compared to its peers Some insider news may be!!!

Analyst Ratings
Cantor Fitzgerald Overweight Jul 10, 24
Piper Sandler Overweight Jun 26, 24
Cantor Fitzgerald Overweight Jun 12, 24
JP Morgan Overweight May 30, 24
Baird Outperform May 30, 24
Cantor Fitzgerald Overweight May 3, 24
Oppenheimer Outperform May 3, 24
Cantor Fitzgerald Overweight Apr 10, 24
Cantor Fitzgerald Overweight Mar 8, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Palmer Eric P See Remarks See Remarks Feb 02 Sell 325 5,684 1,847,300 45,564 02/06/24
Palmer Eric P See Remarks See Remarks Feb 02 Option 139.22 6,701 932,913 46,581 02/06/24
Ryan Cynthia EVP, CHRO EVP, CHRO Aug 29 Sell 282.22 3,768 1,063,405 5,503 08/31/23
Ryan Cynthia EVP, CHRO EVP, CHRO Aug 29 Option 149.14 3,446 513,936 5,937 08/31/23
Jones Nicole S EVP, General Counsel EVP, General Counsel Aug 21 Sell 276.8600 7,819 2,164,768 30,069 08/23/23
Agoglia Hoeltzel Mary T SVP Tax & Chief Acct.. SVP Tax & Chief Acct. Officer Aug 08 Sell 291 12,250 3,564,750 2,093 08/10/23
Agoglia Hoeltzel Mary T SVP Tax & Chief Acct.. SVP Tax & Chief Acct. Officer Aug 08 Option 78.04 4,500 351,180 14,343 08/10/23
Evanko Brian C EVP, Chief Financial.. EVP, Chief Financial Officer Aug 02 Sell 300 2,307 692,100 31,332 08/04/23
Evanko Brian C EVP, Chief Financial.. EVP, Chief Financial Officer Aug 02 Option 78.04 2,877 224,521 31,902 08/04/23
Neville Everett EVP, Solutions & Cor.. EVP, Solutions & Corp Devt. Jul 19 Sell 295.21 13,157 3,884,078 4,937 07/21/23
Neville Everett EVP, Solutions & Cor.. EVP, Solutions & Corp Devt. Jul 19 Option 210.95 14,207 2,996,967 5,987 07/21/23
Sanford Paul A EVP Operations EVP Operations Jul 19 Sell 295.2100 1,507 444,881 8,679 07/21/23
Neville Everett EVP, Solutions & Cor.. EVP, Solutions & Corp Devt. Jul 10 Sell 277.6100 466 129,366 4,937 07/12/23
ZARCONE DONNA F Director Director May 01 Sell 253.2900 757 191,741 25,558 05/03/23
Ryan Cynthia EVP, CHRO EVP, CHRO Feb 24 Sell 294.06 803 236,130 6,503 02/28/23
Neville Everett EVP, Solutions & Cor.. EVP, Solutions & Corp Devt. Feb 24 Sell 294.06 1,772 521,074 9,558 02/28/23
Cordani David Chairman & CEO Chairman & CEO Feb 24 Sell 294.06 20,148 5,924,721 120,496 02/28/23
Jones Nicole S EVP, General Counsel EVP, General Counsel Feb 24 Sell 294.06 5,404 1,589,100 39,697 02/28/23
Ryan Cynthia EVP, CHRO EVP, CHRO Dec 16 Option 139.22 3,749 521,936 5,059 12/19/22
Ryan Cynthia EVP, CHRO EVP, CHRO Dec 16 Sell 327.95 3,009 986,802 4,319 12/19/22
Sadler Jason D Pres., International.. Pres., International Markets Dec 08 Option 190.4 21,169 4,030,578 40,252 12/12/22
Sadler Jason D Pres., International.. Pres., International Markets Dec 08 Sell 334.05 16,667 5,567,611 35,750 12/12/22
Triplett Michael W President, U.S. Comm.. President, U.S. Commercial Sep 12 Option 139.22 8,509 1,184,623 27,540 09/14/22
Triplett Michael W President, U.S. Comm.. President, U.S. Commercial Sep 12 Sell 292.76 8,260 2,418,198 25,091 09/14/22
Sanford Paul A EVP Operations EVP Operations Aug 09 Sell 285.0000 374 106,590 9,121 08/11/22
Agoglia Hoeltzel Mary T SVP Tax & Chief Acct.. SVP Tax & Chief Acct. Officer Aug 09 Option 58.73 7,044 413,694 15,542 08/11/22
Agoglia Hoeltzel Mary T SVP Tax & Chief Acct.. SVP Tax & Chief Acct. Officer Aug 09 Sell 286.89 7,044 2,020,853 8,498 08/11/22
Neville Everett EVP, Strat, Corp Dev.. EVP, Strat, Corp Dev/Solutions Aug 01 Sell 273.9800 902 247,130 6,764 08/03/22
Palmer Eric P President & CEO, Eve.. President & CEO, Evernorth Jul 07 Option 120.9 6,417 775,815 40,838 07/11/22
Palmer Eric P President & CEO, Eve.. President & CEO, Evernorth Jul 07 Sell 275 6,521 1,793,275 39,978 07/11/22
Neville Everett EVP, Strat, Corp Dev.. EVP, Strat, Corp Dev/Solutions Jul 07 Option 192.02 5,560 1,067,631 7,666 07/11/22
Neville Everett EVP, Strat, Corp Dev.. EVP, Strat, Corp Dev/Solutions Jul 07 Sell 275 5,094 1,400,850 7,200 07/11/22
Sanford Paul A EVP Operations EVP Operations Jul 07 Sell 275.0000 374 102,850 9,495 07/11/22
Sadler Jason D Pres., International.. Pres., International Markets Jul 08 Option 149.14 12,402 1,849,634 35,750 07/11/22
Sadler Jason D Pres., International.. Pres., International Markets Jul 08 Sell 280 9,505 2,661,400 32,853 07/11/22
Sadler Jason D Pres., International.. Pres., International Markets Jun 28 Option 139.22 4,562 635,122 32,853 06/30/22
Sadler Jason D Pres., International.. Pres., International Markets Jun 28 Sell 270 3,458 933,660 31,749 06/30/22
Cordani David Chairman & CEO Chairman & CEO May 17 Sell 270.78 45,261 12,255,774 160,499 05/19/22
Cordani David Chairman & CEO Chairman & CEO May 17 Option 120.9 53,130 6,423,417 168,368 05/19/22
Jones Nicole S EVP, General Counsel EVP, General Counsel May 17 Option 139.22 6,781 944,051 37,788 05/19/22
Jones Nicole S EVP, General Counsel EVP, General Counsel May 17 Sell 270 5,901 1,593,270 36,908 05/19/22
Cordani David Chairman & CEO Chairman & CEO Apr 20 Option 120.9 60,753 7,345,038 160,499 04/22/22
Cordani David Chairman & CEO Chairman & CEO Apr 20 Sell 267.45 45,380 12,136,881 152,750 04/22/22
Jones Nicole S EVP, General Counsel EVP, General Counsel Apr 20 Option 139.22 6,781 944,051 36,908 04/22/22
Jones Nicole S EVP, General Counsel EVP, General Counsel Apr 20 Sell 265 5,918 1,568,270 36,045 04/22/22
Jones Nicole S EVP, General Counsel EVP, General Counsel Apr 18 Option 139.22 6,780 943,912 36,045 04/20/22
Jones Nicole S EVP, General Counsel EVP, General Counsel Apr 18 Sell 259.05 12,070 3,126,734 35,201 04/20/22
Cordani David Chairman & CEO Chairman & CEO Apr 18 Option 120.9 45,505 5,501,554 186,914 04/20/22
Cordani David Chairman & CEO Chairman & CEO Apr 18 Sell 261.17 45,505 11,884,541 145,126 04/20/22
Palmer Eric P President & CEO, Eve.. President & CEO, Evernorth Apr 06 Option 78.04 7,967 621,745 40,942 04/08/22